+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anorexia Nervosa Drug"

Anorexia - Pipeline Insight, 2024 - Product Thumbnail Image

Anorexia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Anorexia Nervosa - Pipeline Insight, 2024 - Product Thumbnail Image

Anorexia Nervosa - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 60 Pages
  • Global
From
From
Anorexia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Anorexia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Anorexia Nervosa Drug market is a subset of the Mental Disorders Drugs market. It is composed of drugs used to treat anorexia nervosa, a serious mental disorder characterized by an abnormally low body weight, an intense fear of gaining weight, and a distorted perception of body weight. Common drugs used to treat anorexia nervosa include selective serotonin reuptake inhibitors (SSRIs), antipsychotics, and mood stabilizers. These drugs are used to reduce anxiety, improve mood, and reduce the risk of relapse. The Anorexia Nervosa Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca, and Novartis. Other companies include Sun Pharmaceuticals, Teva Pharmaceuticals, and Mylan. Show Less Read more